Cerulean Pharma Inc. (NASDAQ:CERU) provided an update on corporate activities during the quarter ended June 30, 2015. Generated approximately $40.3 million in gross proceeds from an underwritten public offering of common stock, including full exercise of the underwriters’ overallotment option. Granted Fast Track designation by the US Food and Drug Administration, or FDA, for CRLX101 in combination with Avastin in metastatic RCC in patients who have progressed through two or three prior lines of therapy. Granted Orphan designation for CRLX101 by the FDA for the treatment of ovarian cancer Cerulean Pharma Inc. (NASDAQ:CERU) belongs to Healthcare sector. Its weekly performance is -2.48%. On last trading day company shares ended up $3.94. Cerulean Pharma Inc. (NASDAQ:CERU) distance from 50-day simple moving average (SMA50) is -13.50%.
Amarin Corporation plc (NASDAQ:AMRN) announced a United States District Court has ruled that Amarin may promote to healthcare professionals certain uses of Amarin’s lead product, Vascepa®(icosapent ethyl) capsules, that are not covered by current FDA-approved labeling for the drug so long as the promotion is truthful and non-misleading. The Court declaration covers promotion of the FDA-reviewed and agreed effects of Vascepa demonstrated in the ANCHOR clinical trial of patients with persistently high triglycerides after statin therapy and use of peer-reviewed scientific publications that present the current state of scientific research related to the potential of Vascepa to reduce the risk of cardiovascular disease. Based on today’s ruling Amarin plans to begin promotional activities consistent with the opinion as soon as possible. Amarin Corporation plc (NASDAQ:AMRN) shares moved up 14.22% in last trading session and ended the day at $2.33. AMRN Gross Margin is 63.00% and its return on assets is -32.20%. Amarin Corporation plc (NASDAQ:AMRN) quarterly performance is 25.95%.
Rowan Cos. (NYSE:RDC) on Aug 05, reported second-quarter profit of $84.7 million. The Houston-based company said it had profit of 68 cents per share. Earnings, adjusted for non-recurring costs, were 70 cents per share. On 07 August, Rowan Companies plc (NYSE:RDC) shares fell -2.81% and was closed at $17.28. RDC EPS growth in last 5 year was -18.50%. Rowan Companies plc (NYSE:RDC) year to date (YTD) performance is -25.21%.
Demand Media Inc. (NYSE:DMD) on Thursday reported a loss of $14.4 million in its second quarter. On a per-share basis, the Santa Monica, California-based company said it had a loss of 73 cents. Losses, adjusted for non-recurring costs and pretax expenses, were 24 cents per share. Demand Media, Inc. (NYSE:DMD) ended the last trading day at $5.16. Company weekly volatility is calculated as 8.13% and price to cash ratio as 2.16. Demand Media, Inc. (NYSE:DMD) showed a weekly performance of -13.28%.